UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up

Annals of oncology, 2020-10, Vol.31 (10), p.1306-1319

2020

Volltextzugriff (PDF)

Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas

The lancet oncology, 2011-06, Vol.12 (6), p.583-593

2011

Volltextzugriff (PDF)

Efficacy of anti-epileptic drugs in patients with gliomas and seizures

Journal of neurology, 2009-09, Vol.256 (9), p.1519-1526

2009

Volltextzugriff (PDF)

Neurological and vascular complications of primary and secondary brain tumours: EANO-ESMO Clinical Practice Guidelines for prophylaxis, diagnosis, treatment and follow-up

Annals of oncology, 2021-02, Vol.32 (2), p.171-182

2021

Volltextzugriff (PDF)

Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial

British journal of cancer, 2014-05, Vol.110 (10), p.2427-2433

2014

Volltextzugriff (PDF)

Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients

Annals of oncology, 2011-09, Vol.22 (9), p.2107-2112

2011

Volltextzugriff (PDF)

Symptoms and medication management in the end of life phase of high-grade glioma patients

Journal of neuro-oncology, 2014-12, Vol.120 (3), p.589-595

2014

Volltextzugriff (PDF)

End of life care in high-grade glioma patients in three European countries: a comparative study

Journal of neuro-oncology, 2014-11, Vol.120 (2), p.303-310

2014

Volltextzugriff (PDF)

Development of a questionnaire measuring instrumental activities of daily living (IADL) in patients with brain tumors: a pilot study

Journal of neuro-oncology, 2017-03, Vol.132 (1), p.145-153

2017

Volltextzugriff (PDF)

Clinical applicability of and changes in perfusion MR imaging in brain metastases after stereotactic radiotherapy

Journal of neuro-oncology, 2018-05, Vol.138 (1), p.133-139

2018

Volltextzugriff (PDF)

Health-related quality of life after chemotherapy with or without rituximab in primary central nervous system lymphoma patients: results from a randomised phase III study

Annals of oncology, 2020-08, Vol.31 (8), p.1046-1055

2020

Volltextzugriff (PDF)

Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational study

Journal of neuro-oncology, 2019-05, Vol.142 (3), p.463-470

2019

Volltextzugriff (PDF)

Development and psychometric evaluation of item banks for memory and attention – supplements to the EORTC CAT Core instrument

Health and quality of life outcomes, 2023-11, Vol.21 (1), p.1-124, Article 124

2023

Volltextzugriff (PDF)

Interobserver variability in the radiological assessment of magnetic resonance imaging (MRI) including perfusion MRI in glioblastoma multiforme

European journal of neurology, 2016-10, Vol.23 (10), p.1528-1533

2016

Volltextzugriff (PDF)

Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study

The Lancet (British edition), 2002-11, Vol.360 (9343), p.1361-1368

2002

Volltextzugriff (PDF)

Phase II Study of First-Line Chemotherapy With Temozolomide in Recurrent Oligodendroglial Tumors: The European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971

Journal of clinical oncology, 2003-07, Vol.21 (13), p.2525-2528

2003

Volltextzugriff (PDF)

The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study

British journal of cancer, 2007-07, Vol.97 (3), p.302-307

2007

Volltextzugriff (PDF)

Neuronavigation and surgery of intracerebral tumours

Journal of neurology, 2006-09, Vol.253 (9), p.1123-1136

2006

Volltextzugriff (PDF)

Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972

Annals of oncology, 2003-04, Vol.14 (4), p.599-602

2003

Volltextzugriff (PDF)

The effect of modafinil on fatigue, cognitive functioning, and mood in primary brain tumor patients: a multicenter randomized controlled trial

Neuro-oncology (Charlottesville, Va.), 2013-10, Vol.15 (10), p.1420-1428

2013

Volltextzugriff (PDF)

Symptoms and problems in the end-of-life phase of high-grade glioma patients

Neuro-oncology (Charlottesville, Va.), 2010-11, Vol.12 (11), p.1162-1166

2010

Volltextzugriff (PDF)

Salvage PCV chemotherapy for temozolomide-resistant oligodendrogliomas

Neurology, 2004-09, Vol.63 (5), p.904-906

2004

Volltextzugriff (PDF)

Cognitive status and quality of life in patients with suspected versus proven low-grade gliomas

Neurology, 2001-03, Vol.56 (5), p.618-623

2001

Volltextzugriff (PDF)

P16.18 INTEROBSERVER VARIABILITY IN THE RADIOLOGICAL ASSESSMENT OF PERFUSION MR IMAGING IN GLIOBLASTOMA MULTIFORME

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (suppl 2), p.ii82-ii82

2014

Volltextzugriff (PDF)

Neurobehavioral Status and Health-Related Quality of Life in Newly Diagnosed High-Grade Glioma Patients

Journal of clinical oncology, 2001-10, Vol.19 (20), p.4037-4047

2001

Volltextzugriff (PDF)

1 – 25 von 368

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(343)
Mit Volltextzugriff
(326)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up

Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas

Efficacy of anti-epileptic drugs in patients with gliomas and seizures

Neurological and vascular complications of primary and secondary brain tumours: EANO-ESMO Clinical Practice Guidelines for prophylaxis, diagnosis, treatment and follow-up

Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial

Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients

Symptoms and medication management in the end of life phase of high-grade glioma patients

End of life care in high-grade glioma patients in three European countries: a comparative study

Development of a questionnaire measuring instrumental activities of daily living (IADL) in patients with brain tumors: a pilot study

Clinical applicability of and changes in perfusion MR imaging in brain metastases after stereotactic radiotherapy

Health-related quality of life after chemotherapy with or without rituximab in primary central nervous system lymphoma patients: results from a randomised phase III study

Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational study

Development and psychometric evaluation of item banks for memory and attention – supplements to the EORTC CAT Core instrument

Interobserver variability in the radiological assessment of magnetic resonance imaging (MRI) including perfusion MRI in glioblastoma multiforme

Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study

Phase II Study of First-Line Chemotherapy With Temozolomide in Recurrent Oligodendroglial Tumors: The European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971

The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study

Neuronavigation and surgery of intracerebral tumours

Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972

The effect of modafinil on fatigue, cognitive functioning, and mood in primary brain tumor patients: a multicenter randomized controlled trial

Symptoms and problems in the end-of-life phase of high-grade glioma patients

Salvage PCV chemotherapy for temozolomide-resistant oligodendrogliomas

Cognitive status and quality of life in patients with suspected versus proven low-grade gliomas

P16.18 INTEROBSERVER VARIABILITY IN THE RADIOLOGICAL ASSESSMENT OF PERFUSION MR IMAGING IN GLIOBLASTOMA MULTIFORME

Neurobehavioral Status and Health-Related Quality of Life in Newly Diagnosed High-Grade Glioma Patients

Suchergebnisse filtern